UNSPSC 42182012: Nasal exam specula or dilators

In this classification, this commodity indicates a product used as a specula or dilator tips associated with nasal exam scopes in a medical setting. US FDA regulates Nasal exam specula or dilators under 21 CFR 878.18 and under FDA product code FXE. Most nations, for tariff and trade purposes, schedule these products under HS 901890.

UNSPSC 42182012 Nasal exam specula or dilators is a Commodity code covering handheld diagnostic instruments used in clinical examination and patient care. State and local governments acquire these items primarily through cooperative purchasing vehicles and master-agreement frameworks that consolidate buying across multiple jurisdictions to achieve volume discounts and standardized pricing. The issuing bodies are predominantly state health and human services departments, state procurement offices administering cooperative purchasing consortia, and participating public entities (counties, municipalities, school districts, and special-purpose districts) that leverage master agreements negotiated through cooperative vehicles rather than issuing individual tenders.

Recent activity centers on NASPO ValuePoint RFP 1433 for medical supplies, sponsored by Idaho state agencies with participation from South Dakota as the administering state and open to state and local entities across multiple states. The RFP, posted October 6, 2026 with proposals due November 9, 2026, seeks master-agreement proposals for medical supplies including diagnostic equipment such as nasal specula. Vendors submit via Idaho's procurement system or the NASPO ValuePoint website and must provide comprehensive product catalogs and competitive unit pricing. The cooperative framework allows individual agencies to draw from established pricing and terms as items are ordered, with funding flowing from departmental appropriations. Set-asides or small-business preferences may apply per state policy but are not specified in available documentation. A second nearly identical NASPO ValuePoint solicitation (RFP 1433, posted September 25, 2026, also due November 9, 2026 at 5:00 p.m. Mountain Time) confirms the same master-agreement structure. No recent opportunities specific to nasal exam specula alone appear in the block; procurement activity is consolidated within broader medical-supplies cooperative vehicles.